Variant report
Variant | nsv213366 |
---|---|
Chromosome Location | chr2:47013868-47015334 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370596385 | chr2:47013868-47013869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7423028 | chr2:47013872-47013873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562130962 | chr2:47013878-47013879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374310948 | chr2:47013883-47013884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201682006 | chr2:47013891-47013892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558996233 | chr2:47013892-47013893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199592575 | chr2:47013899-47013900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11684193 | chr2:47013939-47013940 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs546627087 | chr2:47013994-47013995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536585503 | chr2:47013995-47013996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189085498 | chr2:47013996-47013997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs59504281 | chr2:47014041-47014042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183173876 | chr2:47014055-47014056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576478038 | chr2:47014073-47014074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537068384 | chr2:47014167-47014168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113044892 | chr2:47014240-47014241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371243807 | chr2:47014247-47014248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577339207 | chr2:47014287-47014288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140986348 | chr2:47014288-47014289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541613259 | chr2:47014322-47014323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150205897 | chr2:47014344-47014345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574774577 | chr2:47014384-47014385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542142768 | chr2:47014402-47014403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192019813 | chr2:47014426-47014427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531300942 | chr2:47014445-47014446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534913398 | chr2:47014464-47014465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34606703 | chr2:47014522-47014523 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs184085279 | chr2:47014551-47014552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574534632 | chr2:47014574-47014575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547604732 | chr2:47014582-47014583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7606976 | chr2:47014615-47014616 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs189665132 | chr2:47014618-47014619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111619514 | chr2:47014629-47014630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76584498 | chr2:47014630-47014631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569977177 | chr2:47014652-47014653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563367742 | chr2:47014670-47014671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7568137 | chr2:47014686-47014687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs545527079 | chr2:47014742-47014743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58200475 | chr2:47014797-47014798 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs570917799 | chr2:47014809-47014810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534837680 | chr2:47014814-47014815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553127168 | chr2:47014829-47014830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181143482 | chr2:47014930-47014931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542032858 | chr2:47014931-47014932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142906664 | chr2:47014945-47014946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76049540 | chr2:47014960-47014961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113023521 | chr2:47014961-47014962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75078399 | chr2:47014974-47014975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79675266 | chr2:47014975-47014976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147001951 | chr2:47015071-47015072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hypotonia | 17579669 | CNVD |
Hypotonia-Cystinuria syndrome | 16385448 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cystinuria | 17625506 | CNVD |
Breast cancer | 16272173 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:47008200-47021000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:47009800-47025200 | Weak transcription | Right Ventricle | heart |
3 | chr2:47010000-47015000 | Weak transcription | Psoas Muscle | Psoas |
4 | chr2:47014200-47014400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr2:47014400-47015800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |